Week 11

Academic Drug Discovery

Submitted by chem nerd on Wed, 12/07/2011 - 09:22

November 10, 2011 was the last event of our series of guest speakers for the semester, our presentation was brought to us by Thomas Lukas, Ph.D..  Dr. Lukas is currently a professor at Notre Dame, and spoke to us about what it is like doing drug research in an academic setting. I was able to learned about target discover and validation. Dr. Lukas was very insightful and easy to follow as he walked us through the experimentation process.

Alzheimer’s and Lou Gehrig’s disease

Submitted by redpigsue on Wed, 11/16/2011 - 23:21

Dr. Thomas Lukas is a research professor of the Department of Molecular Pharmacology and Biological Chemistry at Northwestern University. The topic he brought was about drugs. His topic was “Alzheimer’s and Lou Gehrig’s disease”. It is interesting how they discovered such drugs that are helpful for “heavy” diseases.

Academic Drug Discovery

Submitted by sam.uelkang on Wed, 11/16/2011 - 23:04

On Thursday, November 11, 2011, Dr. Thomas Lukas, a research professor in the Department of Molecular Pharmacology and Biological Chemistry at Northwestern University came to speak to us about “Academic Drug Discover for Neurodegenerative Diseases.”

Drug Discovery for Alzheimer’s and Lou Gehrig’s

Submitted by petercho614 on Wed, 11/16/2011 - 21:02

Dr. Thomas Lukas visited Andrews University on November 10 Thursday, and gave a presentation about studies of  “Drug Discovery for Alzheimer’s and Lou Gehrig’s”. Dr. Thomas Lukas is a research professor of Molecular Pharmacology & Biological Chemistry at Northwestern University. He graduated from King’s College with B.S and went to John Carroll University and received M.S. Then he received Ph.D. from Rutgers University.

"Drug discovery for Glaucoma, Alzheimer’s, and Lou Gehrig’s diseases"

Submitted by soonho90 on Tue, 11/15/2011 - 14:47

          Dr. Thomas Lukas presented his seminar, "Drug discovery for Glaucoma, Alzheimer’s, and Lou Gehrig’s diseases" on Thursday, November 10, 2011.  Currently, he is a Research Professor in the Department of Molecular Pharmacology & Biological Chemistry at Northwestern University.  He did postdoctoral work at Rockefeller University in the Bruce Merritt laboratory and was on the Pharmacology faculty of Vanderbilt University prior to joining Northwestern University in 1994.

The Growing Role of Academic Drug Discovery

Submitted by tcourtne on Mon, 11/14/2011 - 07:08

On Thursday, November 11, Thomas Lukas, Ph.D., spoke on “Academic Drug Discovery for Neurodegenerative Diseases”.

Big pharmaceutical companies used to do all of their own research and development, but now they are outsourcing much of the R&D to small start-ups. Academic drug discovery is also growing in importance. This can include both basic research and clinical trials. The goal of this translational research is to accelerate the process of getting a drug from “bench to bedside”.

Syndicate content